Published February 2007 | Version v1
Journal article

The clinical value of proton magnetic resonance spectroscopy in adult brain tumours

  • 1. Department of Radiology, Guy's and St Thomas' Hospitals, London (United Kingdom)
  • 2. Cancer Research UK Biomedical Magnetic Resonance Research Group, Basic Medical Sciences, St. George's, University of London (United Kingdom)
  • 3. Department of Radiology, Great Ormond Street Hospital, London (United Kingdom)

Description

Proton magnetic resonance spectroscopy (1H MRS) non-invasively provides information on the biochemical profile (typically including up to nine metabolites and mobile lipids) of brain tissue, which varies according to the underlying disease process. A number of studies have assessed its accuracy in the diagnosis of adult brain tumours. This article describes the basic principles of 1H MRS, the metabolic profiles of different brain tumours, and practical points to aid interpretation of spectra. The literature is reviewed regarding the role of 1H MRS in the diagnosis of brain tumours and more specifically where it has proven to be of additional benefit over conventional magnetic resonance imaging

Additional details

Identifiers

DOI
10.1016/j.crad.2006.09.012;
PII
S0009-9260(06)00315-1;

Publishing Information

Journal Title
Clinical Radiology
Journal Volume
62
Journal Issue
2
Journal Page Range
p. 109-119
ISSN
0009-9260
CODEN
CLRAAG

Optional Information

Copyright
Copyright (c) 2006 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.